Navigation Links
Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
Date:4/27/2009

d or underperforming branded pharmaceutical products and implement life cycle management techniques to maximize the value of its currently marketed products, newly acquired products and product candidates that are in development.

Safe Harbor Statement

Statements in this press release regarding the progress and timing of our product development programs and related trials; our future opportunities; our strategy, future operations, financial position, future revenues and projected costs; our management's prospects, plans and objectives; and any other statements about management's future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Any statements that are not statements of historical fact (including, without limitation, statements containing the words "believes," "plans," "could," "anticipates," "expects," "estimates," "plans," "should," "target," "will," "would" and similar expressions) should also be considered to be forward-looking statements.

There are a number of important factors that could cause our actual results or events to differ materially from those indicated by such forward-looking statements, including risks relating to our ability to develop and maintain the necessary sales, marketing, supply chain, distribution and manufacturing capabilities to commercialize our products, including difficulties relating to the manufacturing of ZYFLO CR(R) tablets; the possibility that the Food and Drug Administration (the FDA) will take enforcement action against us or one or more of our marketed drugs which do not have FDA-approved marketing applications; patient, physician and third-party payor acceptance of our products as safe and effective therapeutic products; our heavy dependence on the commercial success of a small number of currently marketed products;
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development
2. Cornerstone Therapeutics Announces New Board of Directors
3. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
4. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
5. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
6. Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
7. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
8. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
9. TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
10. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
11. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Every year at this time, ... it. However, few are prepared to face the academic workload confronting them. They just ... haven’t prepared them since schools don’t teach students how to study. , “Bankers bank. ...
(Date:9/2/2015)... ... 02, 2015 , ... World Patent Marketing, a vertically integrated ... invention that protects people from crime and other hostile situations. , "The Security ... and Creative Director of World Patent Marketing. "The industry is growing at a ...
(Date:9/2/2015)... ... ... Ovarian cancer continues to be the deadliest of all gynecologic cancers. According ... lifetime is approximately 1 in 75. This year it is estimated that approximately 22,000 ... , There is no test to detect ovarian cancer. A Pap test does not ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream ... cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for intense ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy ... been named to the Inc. 5000 List, an independent ranking of the ... for 34 years, and this achievement puts Canopy in rarefied company. Over the ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2
... that about 44% of women are victims of intimate ... mental health. // Screening for it is inadequate, and ... and the June issue of the American Journal of ... in addressing this issue. ,With colleagues from ...
... that both lesbians and heterosexual men react in a similar ... to a previous study it was found that there were ... and homosexual men. Pheromones are sex-specific chemicals that send messages ... in animals, but their existence in humans is questionable. Researchers ...
... Health Research at King's College London said that British soldiers ... the researcher and his team are examining whether there had ... Iraq. Therefore they are comparing the mental and physical health ... who had not. In the end they found out that ...
... Pharmacology states that 10% or more accidental and unwanted pregnancies ... //as they have the advantage of easy access. ,UK ... University of Bradford looked at 203 females aged from 13 ... and community pharmacies. ,They discovered that those ...
... athletes seem to have a negative impact on their children's ... Journal of Sports Medicine. ,The findings are informed ... in the US, which looked at the role parents play ... all spent an average of 17 years in the business. ...
... recent BBC survey it is found that there is a ... that about one in seven patients// take illegal drugs on ... use is very common among patients. It is said that ... every year. But Oliver Treacy, borough director for mental health ...
Cached Medicine News:Health News:Research into Intimate Partner Violence 2Health News:Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies 2Health News:Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies 3Health News:Parents of Junior Athletes do More Harm than Good 2
(Date:9/2/2015)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China ... plasma-based biopharmaceutical company in China ... Taibang Biological Products Co., Ltd. ("Guizhou Taibang") entered ... Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan") to ... to source no less than 500 tonnes of ...
(Date:9/2/2015)... Quebec , Sept. 2, 2015  Valeant Pharmaceuticals ... today announced that its affiliate has entered into a ... USA , Inc. (NASDAQ: SURG ) ... the upfront cash payment, Synergetics stockholders will receive additional ... specified sales milestones are achieved following the closing.  The ...
(Date:9/2/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ), ... oncology with an emphasis on the treatment of primary ... participate in the upcoming 17 th Annual Rodman ... at the St. Regis Hotel in New York City.  ... and Chief Executive Officer, will present a corporate overview ...
Breaking Medicine Technology:China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Delcath To Present At The 17th Annual Rodman & Renshaw Conference 2Delcath To Present At The 17th Annual Rodman & Renshaw Conference 3
... 20, 2011 Perrigo Company (Nasdaq: PRGO; TASE) today ... acquire substantially all of the assets of Paddock Laboratories, ... generic pharmaceutical products for approximately $540 million in cash. ... a result of the acquisition of Paddock,s assets. The ...
... Jan. 20, 2011 Reportlinker.com announces that a ... catalogue: Hospital Angiography Census ... is the most comprehensive European market report on ... Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology ...
Cached Medicine Technology:Perrigo to Acquire Assets of Paddock Labs for $540 Million 2Perrigo to Acquire Assets of Paddock Labs for $540 Million 3Perrigo to Acquire Assets of Paddock Labs for $540 Million 4Perrigo to Acquire Assets of Paddock Labs for $540 Million 5Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... viscoelastic insert runs alongside the Achilles ... and targeted intermittent compression during movement. ... irritation of the Achilles tendon is ... wedge (raises heel about 6 mm). ...
... while maintaining the ankle in functional alignment. ... soft, cushioning AliPlast™ foam liner. The cushioning ... the heel in a protective hammock, reducing ... in bed from side-lying to supine. Only ...
... combines the therapeutic benefits of controlled compression ... to minimize pain. The cuff is anatomically ... maximum cryotherapy. The Ankle Cryo/Cuff is one-size ... a pediatric size.,All Cryo/Cuffs can be ordered ...
Medicine Products: